Osimertinib 40Mg - 搜索视频

最匹配的结果

Dr. Goldberg Discusses Osimertinib in NSCLC

Dr. Goldberg Discusses Osimertinib in NSCLC

2018年3月23日

Osikin 80mg Osimertinib Tablet

Osikin 80mg Osimertinib Tablet

Dr. Goldberg on Sequencing Following Treatment With Osimertinib in NSCLC

Dr. Goldberg on Sequencing Following Treatment With Osimertinib in NSCLC

2018年4月12日

FLAURA2: Osimertinib and Chemotherapy in Frontline EGFR-Mutant NSCLC

FLAURA2: Osimertinib and Chemotherapy in Frontline EGFR-Mutant NSCLC

2023年12月15日

WCLC 2024 Insights: MARIPOSA - Amivantamab Lazertinib vs. Osimertinib in 1L EGFR-Mut Advanced NSCLC

WCLC 2024 Insights: MARIPOSA - Amivantamab Lazertinib vs. Osimertinib in 1L EGFR-Mut Advanced NSCLC

80mg Tagrisso Osimertinib Tablets

80mg Tagrisso Osimertinib Tablets

Buy Indian Osimertinib Tablet Price Online Philippines

Buy Indian Osimertinib Tablet Price Online Philippines

已浏览 42 次2023年8月19日

Tagrisso Osimertinib 80 Mg Tablets

How Much Does Osimertinib 80mg Tablet Cost

已浏览 47 次2023年11月16日

Adjuvant Osimertinib in Early-Stage NSCLC: The ADAURA Trial

2022年7月19日

EGFR-Mutated NSCLC: Treatment Options Following Progression on Osimertinib

2023年10月19日

Clinical Insights on Osimertinib in Frontline Therapy for EGFR-Mutated NSCLC

Dr. Pennell on Understanding the Cost-Effectiveness of Osimertinib in NSCLC

2021年6月22日

ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Therapy in Patients With Resected EGFRm Stage IB–IIIA NSCLC

已浏览 643 次2022年12月3日

ESMO 2024 Insights: Acquired Resistance to 1L Amivantamab Lazertinib vs. Osimertinib in EGFR-Mutant aNSCLC - Early MARIPOSA Study Analysis

已浏览 121 次4 个月之前

Predictive Biomarkers for Treatment With Amivantamab Plus Lazertinib Among EGFR-Mutated NSCLC in the Post-Osimertinib Setting: Analysis of Tissue IHC and ctDNA NGS

UNICORN Study: Osimertinib and Other Emerging Treatments for Uncommon EGFR Mutations

2023年12月27日

Budget 2024: Government to fully exempt 3 cancer drugs from customs duty

Osimertinib Monotherapy vs. Combination Therapy: Patient Selection in EGFR-Mutant Advanced NSCLC

Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) With Biomarkers of High-Risk Disease: A Secondary Analysis From the Phase 3 MARIPOSA Study

Dr Ramalingam on Osimertinib Post-Chemoradiotherapy in Unresectable, Stage III, EGFR-Mutated NSCLC

Dr Haggstrom on the Role of Osimertinib in Unresectable EGFR-Mutated NSCLC

Dr Jänne on the FDA Approval of Osimertinib Plus Chemotherapy in EGFR mNSCLC

11 个月之前

Osimertinib (osi) After Definitive Chemoradiotherapy (CRT) in Patients (pts) With Unresectable Stage (stg) III Epidermal Growth Factor Receptor-Mutated (EGFRm) NSCLC: Primary Results of the Phase 3 LAURA Study

Amivantamab Lazertinib Versus Osimertinib as 1L Treatment in EGFR-Mutated Advanced NSCLC: Primary Results From MARIPOSA

2023年11月10日

LAURA: Osimertinib after Definitive CRT in Unresectable Stage III NSCLC with EGFR Mutations

targetedonc.com

Tumor burden in EGFR-mutant NCSCLC impacts overall survival

clevelandclinic.org

WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC

已浏览 170 次5 个月之前

कैंसर की ये 3 दवाएं हुईं सस्ती, कितनी है इनकी कीमत... क्या हैं इनके लाभ जानिए

news24online.com

Il farmaco Osimertinib Tagrisso di AstraZeneca possibile cura per il tumore al polmone: "Efficace all'84%"

观看更多视频